Sign in

NCT06096246Recruiting

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Objective Randomised Blinded Investigation of Cardioversion Versus Ablation for Persistent Atrial Fibrillation (ORBICA-AF)

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
208 (estimated)
First submitted
21 Sept 2023
Start date
26 Jul 2024
Primary completion date
26 Jul 2027
Lead sponsor
Barts & The London NHS Trust
NCT number
NCT06096246

What you commit to

  • Study type: Interventional
  • Planned participants: 208
  • From 26 Jul 2024 to the primary completion date, 26 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients in Persistent AF who have had more than one previous cardioversion.

Other illness

  • Uncontrolled hypertension

Lab values

  • Creatinine clearance (eGFR) \< 30mls/min

Other

  • Contraindication or unable to take anticoagulation
  • Contraindication for catheter ablation
  • BMI \> 40
  • Established diagnosis of Hypertrophic cardiomyopathy

Who the study is looking for

  • Ability to give informed consent
  • Age 18-85 years
  • Persistent AF (atrial fibrillation lasting \> 7days) of total continuous duration \<2 years as documented in medical notes.
  • Patients being considered for cardioversion.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Barts Heart Centre
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.